We bring you the latest news from the healthcare about the health care in the United Kingdom. Do your have news for us? Contact the editor. Watch also this special movie.

dinsdag 25 april 2017

Latest content from npj Precision Oncology: 25 April 2017

If you are unable to see the message below, click here to view.
npj Precision Oncology

Table of Contents: April 2017

Comment | 24 April 2017

Precision medicine: the foundation of future cancer therapeutics

Seung Ho Shin, Ann M. Bode & Zigang Dong

npj Precision Oncology 1, Article number: 12 | doi:10.1038/s41698-017-0016-z

Review Article | 20 April 2017

Endothelial cell malignancies: new insights from the laboratory and clinic

Michael J. Wagner, Vinod Ravi, David G. Menter & Anil K. Sood

npj Precision Oncology 1, Article number: 11 | doi:10.1038/s41698-017-0013-2

Article | 17 April 2017

The lack of increases in circulating endothelial progenitor cell as a negative predictor for pathological response to neoadjuvant chemotherapy in breast cancer patients

Sunao Tanaka, Takayuki Ueno, Hiroshi Ishiguro, Satoshi Morita & Masakazu Toi

npj Precision Oncology 1, Article number: 6 | doi:10.1038/s41698-017-0006-1

Article | 03 April 2017

Inhibiting breast cancer by targeting the thromboxane A2 pathway

Haitao Li, Mee-Hyun Lee, Kangdong Liu, Ting Wang, Mengqiu Song et al.

npj Precision Oncology 1, Article number: 8 | doi:10.1038/s41698-017-0011-4

Article | 03 April 2017

Birinapant sensitizes platinum-resistant carcinomas with high levels of cIAP to carboplatin therapy

V. La, R. Fujikawa, D. M. Janzen, M. Nunez, L. Bainvoll et al.

npj Precision Oncology 1, Article number: 7 | doi:10.1038/s41698-017-0008-z

A supplement to Nature Biotechnology | Nature Reviews Drug Discovery

Check out the latest issue of BioPharma Dealmakers for the latest dealmaking opportunities, and editorials on personalized cancer vaccines based on tumor-specific neoantigens, the expanding network of microbiome partnerships, and impending growth spurt of the dermatology market.

Download the issue for FREE
Your email address is in the npj Precision Oncology mailing list.
You have been sent this alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: myaccount (You will need to log in to be recognised as a nature.com registrant)
For further technical assistance, please contact our registration department
For print subscription enquiries, please contact our subscription department
For other enquiries, please contact our customer feedback department
Springer Nature | One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA
Springer Nature's worldwide offices:
London - Paris - Munich - New Delhi - Tokyo - Melbourne
San Diego - San Francisco - Washington - New York - Boston
Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW.
© 2017 Macmillan Publishers Limited, part of Springer Nature. All rights reserved.
Springer Nature